A pet medicines company is seeking to become one of the few Massachusetts biotechs to go public in 2025.

Akston Biosciences Corp. has filed paperwork with the U.S. Securities and Exchange Commission to begin the initial public offering process.

Stream NBC10 Boston news for free, 24/7, wherever you are. WATCH HERE

More on this story from Boston Business Journal

See Full Page